Ozempic is a drug, designed for diabetics, but which has a game-changing secondary use. It has the power to transform the lives of people with complex obesity. It’s only available in Ireland for people with Type 2 diabetes – and in very limited circumstances for those with obesity. In this episode Bernice Harrison talks to Belinda from Tipperary, who after taking the drug for five months, has lost more than three stone. We also hear from Professor Donal O’Shea, HSE lead on obesity, who explains how the treatment works and how access to it has been put at risk by its association with celebrity weight loss, and its popularity on social media.

Hosted on Acast. See acast.com/privacy for more information.